These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 33881460
21. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. Mouchlianitis E, Bloomfield MA, Law V, Beck K, Selvaraj S, Rasquinha N, Waldman A, Turkheimer FE, Egerton A, Stone J, Howes OD. Schizophr Bull; 2016 May; 42(3):744-52. PubMed ID: 26683625 [Abstract] [Full Text] [Related]
22. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE). Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, Dazzan P, McGuire P. Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882 [Abstract] [Full Text] [Related]
23. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC. Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769 [Abstract] [Full Text] [Related]
24. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia. Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Koike S, Yahata N, Katsura M, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H. Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251 [Abstract] [Full Text] [Related]
25. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study. Galińska-Skok B, Małus A, Konarzewska B, Rogowska-Zach A, Milewski R, Tarasów E, Szulc A, Waszkiewicz N. Dis Markers; 2018 Sep; 2018():3654894. PubMed ID: 30595760 [Abstract] [Full Text] [Related]
26. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study. Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JK, Caravaggio F, Kim J, Alshehri Y, Chakravarty MM, De Luca V, Remington G, Gerretsen P, Graff-Guerrero A. Psychiatry Res Neuroimaging; 2018 Mar 30; 273():16-24. PubMed ID: 29414127 [Abstract] [Full Text] [Related]
27. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA). Egerton A, Murphy A, Donocik J, Anton A, Barker GJ, Collier T, Deakin B, Drake R, Eliasson E, Emsley R, Gregory CJ, Griffiths K, Kapur S, Kassoumeri L, Knight L, Lambe EJB, Lawrie SM, Lees J, Lewis S, Lythgoe DJ, Matthews J, McGuire P, McNamee L, Semple S, Shaw AD, Singh KD, Stockton-Powdrell C, Talbot PS, Veronese M, Wagner E, Walters JTR, Williams SR, MacCabe JH, Howes OD. Schizophr Bull; 2021 Mar 16; 47(2):505-516. PubMed ID: 32910150 [Abstract] [Full Text] [Related]
28. Cannabidiol modulation of hippocampal glutamate in early psychosis. O'Neill A, Annibale L, Blest-Hopley G, Wilson R, Giampietro V, Bhattacharyya S. J Psychopharmacol; 2021 Jul 16; 35(7):814-822. PubMed ID: 33860709 [Abstract] [Full Text] [Related]
29. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration. Egerton A, Griffiths K, Casetta C, Deakin B, Drake R, Howes OD, Kassoumeri L, Khan S, Lankshear S, Lees J, Lewis S, Mikulskaya E, Millgate E, Oloyede E, Pollard R, Rich N, Segev A, Sendt KV, MacCabe JH. Neuropsychopharmacology; 2023 Feb 16; 48(3):567-575. PubMed ID: 36456813 [Abstract] [Full Text] [Related]
30. Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study. Liemburg E, Sibeijn-Kuiper A, Bais L, Pijnenborg G, Knegtering H, van der Velde J, Opmeer E, de Vos A, Dlabac-De Lange J, Wunderink L, Aleman A. Sci Rep; 2016 Feb 23; 6():21873. PubMed ID: 26903078 [Abstract] [Full Text] [Related]
31. Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study. Bustillo JR, Upston J, Mayer EG, Jones T, Maudsley AA, Gasparovic C, Tohen M, Lenroot R. Neuropsychopharmacology; 2020 Oct 23; 45(11):1851-1859. PubMed ID: 32403117 [Abstract] [Full Text] [Related]
32. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C, Canive J, Gasparovic C. JAMA Psychiatry; 2014 Mar 23; 71(3):265-72. PubMed ID: 24402128 [Abstract] [Full Text] [Related]
33. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. Onwordi EC, Whitehurst T, Mansur A, Statton B, Berry A, Quinlan M, O'Regan DP, Rogdaki M, Marques TR, Rabiner EA, Gunn RN, Vernon AC, Natesan S, Howes OD. Transl Psychiatry; 2021 Jul 17; 11(1):393. PubMed ID: 34282130 [Abstract] [Full Text] [Related]
34. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task. Jelen LA, King S, Horne CM, Lythgoe DJ, Young AH, Stone JM. Eur Neuropsychopharmacol; 2019 Dec 17; 29(2):222-234. PubMed ID: 30558824 [Abstract] [Full Text] [Related]
35. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia. Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, Higgs C, Varvaris M, Edden RA, Pomper M, Schretlen D, Barker PB, Sawa A. Curr Mol Med; 2015 Dec 17; 15(2):176-83. PubMed ID: 25732147 [Abstract] [Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
37. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN. Bipolar Disord; 2012 Aug 01; 14(5):478-87. PubMed ID: 22834460 [Abstract] [Full Text] [Related]
38. Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans. White TL, Monnig MA, Walsh EG, Nitenson AZ, Harris AD, Cohen RA, Porges EC, Woods AJ, Lamb DG, Boyd CA, Fekir S. Neuropsychopharmacology; 2018 Jun 01; 43(7):1498-1509. PubMed ID: 29511334 [Abstract] [Full Text] [Related]
39. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder. Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C, Vallada H, Otaduy MC. Eur Neuropsychopharmacol; 2015 Dec 01; 25(12):2221-9. PubMed ID: 26476706 [Abstract] [Full Text] [Related]
40. Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk. Wang J, Tang Y, Zhang T, Cui H, Xu L, Zeng B, Li Y, Li G, Li C, Liu H, Lu Z, Zhang J, Wang J. Neural Plast; 2016 Dec 01; 2016():3915703. PubMed ID: 28003912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]